 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| SYHX2001 / CSPC Pharma
Enrollment open, Metastases: To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Aug 9, 2022
P1, N=176, Recruiting, Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting --> Recruiting
- ||| SYHX2001 / CSPC Pharma
New P1 trial, Metastases: To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Jun 7, 2022
P1, N=176, Not yet recruiting, Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.